Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field
申请人:Naccari Giancarlo
公开号:US20120316230A1
公开(公告)日:2012-12-13
The present invention relates to compounds of formula (I), where R
1
and R
2
, which may be identical or different, are selected from the group comprising H, C
n
H
2n-1
, a linear or branched alkyl group having 1 to 6 carbons, or together form an aromatic or aliphatic ring with 5 or 6 atoms; R
3
is —CO—CH
3
, —NHOH, —OH, or —OR
6
where R
6
is a linear or branched alkyl group having 1 to 6 carbon atoms; R4 is H, linear or branched alkyl group having from 1 to 6 atoms, phenyl, benzyl, —CF
3
or CF
2
CF
3
, vinyl or allyl; R
5
, R
7
, R
8
are hydrogen atoms; or R
3
and R
4
, R
4
and R
5
, or R
7
and R
8
together form a ring, fused to the benzene, aromatic or aliphatic ring with 5 or 6 atoms comprising from 1 to 2 heteroatoms selected independently from the group comprising N, O, and use thereof in the medical field.
本发明涉及式(I)的化合物,其中R1和R2,可以相同也可以不同,选择自H,CnH2n-1,具有1至6个碳的线性或支链烷基团,或者共同形成一个具有5或6个原子的芳香或脂肪环;R3为—CO—CH3,—NHOH,—OH或—OR6,其中R6为具有1至6个碳的线性或支链烷基团;R4为H,具有1至6个原子的线性或支链烷基团,苯基,苄基,—CF3或CF2CF3,乙烯基或丙烯基;R5,R7,R8为氢原子;或者R3和R4,R4和R5,或R7和R8共同形成一个环,与苯环,芳香或脂肪环共同构成一个具有1至2个杂原子的环,独立选择自N,O的群组;以及在医药领域中的应用。